22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › HAEMONETICS CORP. › 2024-2025

HAEMONETICS CORP. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and HAEMONETICS CORP.’s Form 8-K, filed July 25, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 11Ballot items
  • 352Asset managers, any item
  • 4,885Fund votes
  • July 25, 2024Meeting date

Results at a glance

Meeting of July 25, 2024: 11 items on HAEMONETICS CORP.’s Form 8-K, filed July 25, 2024: 2 approved · 9 passed (calculated).

Dissent

No notable dissent.

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore HAEMONETICS CORP. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by HAEMONETICS CORP.

These tallies are HAEMONETICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed July 25, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

HAEMONETICS CORP. — official shareholder meeting results, meeting held July 25, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Christopher A. Simon 47,563,311---- 269,3861,079,553 99.4%Passed (calculated)—
Elect Director: Robert E. Abernathy 47,233,098---- 599,5991,079,553 99%Passed (calculated)—
Elect Director: Diane M. Bryant 47,637,507---- 195,1901,079,553 99.6%Passed (calculated)—
Elect Director: Michael J. Coyle 47,492,931---- 339,7661,079,553 99.3%Passed (calculated)—
Elect Director: Charles J. Dockendorff 46,789,643---- 1,043,0541,079,553 98%Passed (calculated)—
Elect Director: Lloyd E. Johnson 47,243,880---- 588,8171,079,553 99%Passed (calculated)—
Elect Director: Mark W. Kroll 46,938,807---- 893,8901,079,553 98%Passed (calculated)—
Elect Director: Claire Pomeroy 47,553,094---- 279,6031,079,553 99.4%Passed (calculated)—
Elect Director: Ellen M. Zane 47,122,780---- 709,9171,079,553 99%Passed (calculated)—
2. The compensation of the Company's named executive officers 46,230,4661,460,004142,227 --1,079,553 97%Approved—
3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 47,738,7691,049,682123,799 ---- 98%Approved—

Source: HAEMONETICS CORP., Form 8-K, filed with the SEC on July 25, 2024 — read the filing on EDGAR.

How asset managers voted at the HAEMONETICS CORP. 2024-2025 meeting

352 asset managers disclosed a vote on at least one HAEMONETICS CORP. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Charles J. Dockendorff

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 46,789,643WITHHELD: 1,043,054

Prior year: 96.3% for (August 4, 2023 meeting) ▲ 1.5 pts

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Charles J. Dockendorff

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Charles J. Dockendorff”): 46,789,643 for, 1,043,054 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 31,295,701 for, 100,978 withheld.

FOR
FOR: 31,295,701WITHHOLD: 100,978
Largest asset managers voting on “Election of Directors: Charles J. Dockendorff” at HAEMONETICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,196,3510 00For
Capital Group3,681,8750 00For
BlackRock3,247,0690 00For
AMCAP FUND3,053,4800 00For
Neuberger Berman2,265,1050 00For
Fidelity1,277,9810 00For
T. Rowe Price1,206,1850 00For
Royce1,017,8450 00For
Thrivent808,3220 00For
Dimensional763,3450 00For
Franklin Custodian Funds737,2640 00For
Charles Schwab542,2300 00For
FRANKLIN STRATEGIC SERIES485,6000 00For
State Street399,1170 00For
Hartford397,7430 00For
Allspring393,7200 00For
BOSTON TRUST WALDEN FUNDS290,4810 00For
Brighthouse284,8900 00For
HARBOR FUNDS275,0600 00For
John Hancock234,5500 00For
Equitable205,3490 00For
Bridge Builder Trust197,6120 00For
HEARTLAND GROUP INC180,0000 00For
Columbia Threadneedle160,7310 00For
SCHWARTZ INVESTMENT TRUST151,0000 00For

Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).

Elect Director: Christopher A. Simon

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 47,563,311WITHHELD: 269,386

Prior year: 99.3% for (August 4, 2023 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Christopher A. Simon

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Christopher A. Simon”): 47,563,311 for, 269,386 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 31,379,759 for, 16,920 withheld.

FOR
FOR: 31,379,759WITHHOLD: 16,920
Largest asset managers voting on “Election of Directors: Christopher A. Simon” at HAEMONETICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,196,3510 00For
Capital Group3,681,8750 00For
BlackRock3,247,0690 00For
AMCAP FUND3,053,4800 00For
Neuberger Berman2,265,1050 00For
Fidelity1,277,9810 00For
T. Rowe Price1,206,1850 00For
Royce1,017,8450 00For
Thrivent808,3220 00For
Dimensional763,3450 00For
Franklin Custodian Funds737,2640 00For
Charles Schwab542,2300 00For
FRANKLIN STRATEGIC SERIES485,6000 00For
State Street399,1170 00For
Hartford397,7430 00For
Allspring393,7200 00For
BOSTON TRUST WALDEN FUNDS290,4810 00For
Brighthouse284,8900 00For
HARBOR FUNDS275,0600 00For
John Hancock234,5500 00For
Equitable205,3490 00For
Bridge Builder Trust197,6120 00For
HEARTLAND GROUP INC180,0000 00For
Columbia Threadneedle160,7310 00For
SCHWARTZ INVESTMENT TRUST151,0000 00For

Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).

Elect Director: Claire Pomeroy

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 47,553,094WITHHELD: 279,603

Prior year: 99.2% for (August 4, 2023 meeting) ▲ 0.2 pts

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Claire Pomeroy

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Claire Pomeroy”): 47,553,094 for, 279,603 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 31,378,947 for, 17,732 withheld.

FOR
FOR: 31,378,947WITHHOLD: 17,732
Largest asset managers voting on “Election of Directors: Claire Pomeroy” at HAEMONETICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,196,3510 00For
Capital Group3,681,8750 00For
BlackRock3,247,0690 00For
AMCAP FUND3,053,4800 00For
Neuberger Berman2,265,1050 00For
Fidelity1,277,9810 00For
T. Rowe Price1,206,1850 00For
Royce1,017,8450 00For
Thrivent808,3220 00For
Dimensional763,3450 00For
Franklin Custodian Funds737,2640 00For
Charles Schwab542,2300 00For
FRANKLIN STRATEGIC SERIES485,6000 00For
State Street399,1170 00For
Hartford397,7430 00For
Allspring393,7200 00For
BOSTON TRUST WALDEN FUNDS290,4810 00For
Brighthouse284,8900 00For
HARBOR FUNDS275,0600 00For
John Hancock234,5500 00For
Equitable205,3490 00For
Bridge Builder Trust197,6120 00For
HEARTLAND GROUP INC180,0000 00For
Columbia Threadneedle160,7310 00For
SCHWARTZ INVESTMENT TRUST151,0000 00For

Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).

Elect Director: Diane M. Bryant

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 47,637,507WITHHELD: 195,190
Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Diane M. Bryant

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Diane M. Bryant”): 47,637,507 for, 195,190 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 31,378,947 for, 17,732 withheld.

FOR
FOR: 31,378,947WITHHOLD: 17,732
Largest asset managers voting on “Election of Directors: Diane M. Bryant” at HAEMONETICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,196,3510 00For
Capital Group3,681,8750 00For
BlackRock3,247,0690 00For
AMCAP FUND3,053,4800 00For
Neuberger Berman2,265,1050 00For
Fidelity1,277,9810 00For
T. Rowe Price1,206,1850 00For
Royce1,017,8450 00For
Thrivent808,3220 00For
Dimensional763,3450 00For
Franklin Custodian Funds737,2640 00For
Charles Schwab542,2300 00For
FRANKLIN STRATEGIC SERIES485,6000 00For
State Street399,1170 00For
Hartford397,7430 00For
Allspring393,7200 00For
BOSTON TRUST WALDEN FUNDS290,4810 00For
Brighthouse284,8900 00For
HARBOR FUNDS275,0600 00For
John Hancock234,5500 00For
Equitable205,3490 00For
Bridge Builder Trust197,6120 00For
HEARTLAND GROUP INC180,0000 00For
Columbia Threadneedle160,7310 00For
SCHWARTZ INVESTMENT TRUST151,0000 00For

Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).

Elect Director: Ellen M. Zane

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 47,122,780WITHHELD: 709,917

Prior year: 84.8% for (August 4, 2023 meeting) ▲ 13.7 pts

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Ellen M. Zane

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Ellen M. Zane”): 47,122,780 for, 709,917 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 31,289,999 for, 102,252 withheld, 4,428 abstained.

FOR
FOR: 31,289,999ABSTAIN: 4,428WITHHOLD: 102,252
Largest asset managers voting on “Election of Directors: Ellen M. Zane” at HAEMONETICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,196,3510 00For
Capital Group3,681,8750 00For
BlackRock3,247,0690 00For
AMCAP FUND3,053,4800 00For
Neuberger Berman2,265,1050 00For
Fidelity1,277,9810 00For
T. Rowe Price1,206,1850 00For
Royce1,017,8450 00For
Thrivent808,3220 00For
Dimensional763,3450 00For
Franklin Custodian Funds737,2640 00For
Charles Schwab542,2300 00For
FRANKLIN STRATEGIC SERIES485,6000 00For
State Street399,1170 00For
Hartford397,7430 00For
Allspring393,7200 00For
BOSTON TRUST WALDEN FUNDS290,4810 00For
Brighthouse284,8900 00For
HARBOR FUNDS275,0600 00For
John Hancock234,5500 00For
Equitable205,3490 00For
Bridge Builder Trust197,6120 00For
HEARTLAND GROUP INC180,0000 00For
Columbia Threadneedle160,7310 00For
SCHWARTZ INVESTMENT TRUST151,0000 00For

Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).

Elect Director: Lloyd E. Johnson

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 47,243,880WITHHELD: 588,817

Prior year: 90.1% for (August 4, 2023 meeting) ▲ 8.7 pts

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Lloyd E. Johnson

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Lloyd E. Johnson”): 47,243,880 for, 588,817 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 31,343,068 for, 49,183 withheld, 4,428 abstained.

FOR
FOR: 31,343,068ABSTAIN: 4,428WITHHOLD: 49,183
Largest asset managers voting on “Election of Directors: Lloyd E. Johnson” at HAEMONETICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,196,3510 00For
Capital Group3,681,8750 00For
BlackRock3,247,0690 00For
AMCAP FUND3,053,4800 00For
Neuberger Berman2,265,1050 00For
Fidelity1,277,9810 00For
T. Rowe Price1,206,1850 00For
Royce1,017,8450 00For
Thrivent808,3220 00For
Dimensional763,3450 00For
Franklin Custodian Funds737,2640 00For
Charles Schwab542,2300 00For
FRANKLIN STRATEGIC SERIES485,6000 00For
State Street399,1170 00For
Hartford397,7430 00For
Allspring393,7200 00For
BOSTON TRUST WALDEN FUNDS290,4810 00For
Brighthouse284,8900 00For
HARBOR FUNDS275,0600 00For
John Hancock234,5500 00For
Equitable205,3490 00For
Bridge Builder Trust197,6120 00For
HEARTLAND GROUP INC180,0000 00For
Columbia Threadneedle160,7310 00For
SCHWARTZ INVESTMENT TRUST151,0000 00For

Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).

Elect Director: Mark W. Kroll

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 46,938,807WITHHELD: 893,890

Prior year: 98.6% for (August 4, 2023 meeting) ▼ 0.5 pts

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Mark W. Kroll

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Mark W. Kroll”): 46,938,807 for, 893,890 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 31,284,357 for, 112,322 withheld.

FOR
FOR: 31,284,357WITHHOLD: 112,322
Largest asset managers voting on “Election of Directors: Mark W. Kroll” at HAEMONETICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,196,3510 00For
Capital Group3,681,8750 00For
BlackRock3,247,0690 00For
AMCAP FUND3,053,4800 00For
Neuberger Berman2,265,1050 00For
Fidelity1,277,9810 00For
T. Rowe Price1,206,1850 00For
Royce1,017,8450 00For
Thrivent808,3220 00For
Dimensional763,3450 00For
Franklin Custodian Funds737,2640 00For
Charles Schwab542,2300 00For
FRANKLIN STRATEGIC SERIES485,6000 00For
State Street399,1170 00For
Hartford397,7430 00For
Allspring393,7200 00For
BOSTON TRUST WALDEN FUNDS290,4810 00For
Brighthouse284,8900 00For
HARBOR FUNDS275,0600 00For
John Hancock234,5500 00For
Equitable205,3490 00For
Bridge Builder Trust130,7530 066,859Mixed
HEARTLAND GROUP INC180,0000 00For
Columbia Threadneedle160,7310 00For
SCHWARTZ INVESTMENT TRUST151,0000 00For

Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).

Elect Director: Michael J. Coyle

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 47,492,931WITHHELD: 339,766

Prior year: 99.3% for (August 4, 2023 meeting) unchanged

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Michael J. Coyle

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Michael J. Coyle”): 47,492,931 for, 339,766 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 31,379,759 for, 16,920 withheld.

FOR
FOR: 31,379,759WITHHOLD: 16,920
Largest asset managers voting on “Election of Directors: Michael J. Coyle” at HAEMONETICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,196,3510 00For
Capital Group3,681,8750 00For
BlackRock3,247,0690 00For
AMCAP FUND3,053,4800 00For
Neuberger Berman2,265,1050 00For
Fidelity1,277,9810 00For
T. Rowe Price1,206,1850 00For
Royce1,017,8450 00For
Thrivent808,3220 00For
Dimensional763,3450 00For
Franklin Custodian Funds737,2640 00For
Charles Schwab542,2300 00For
FRANKLIN STRATEGIC SERIES485,6000 00For
State Street399,1170 00For
Hartford397,7430 00For
Allspring393,7200 00For
BOSTON TRUST WALDEN FUNDS290,4810 00For
Brighthouse284,8900 00For
HARBOR FUNDS275,0600 00For
John Hancock234,5500 00For
Equitable205,3490 00For
Bridge Builder Trust197,6120 00For
HEARTLAND GROUP INC180,0000 00For
Columbia Threadneedle160,7310 00For
SCHWARTZ INVESTMENT TRUST151,0000 00For

Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).

Elect Director: Robert E. Abernathy

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 47,233,098WITHHELD: 599,599

Prior year: 96.4% for (August 4, 2023 meeting) ▲ 2.3 pts

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Robert E. Abernathy

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Robert E. Abernathy”): 47,233,098 for, 599,599 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 31,317,164 for, 75,087 withheld, 4,428 abstained.

FOR
FOR: 31,317,164ABSTAIN: 4,428WITHHOLD: 75,087
Largest asset managers voting on “Election of Directors: Robert E. Abernathy” at HAEMONETICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,196,3510 00For
Capital Group3,681,8750 00For
BlackRock3,247,0690 00For
AMCAP FUND3,053,4800 00For
Neuberger Berman2,265,1050 00For
Fidelity1,277,9810 00For
T. Rowe Price1,206,1850 00For
Royce1,017,8450 00For
Thrivent808,3220 00For
Dimensional763,3450 00For
Franklin Custodian Funds737,2640 00For
Charles Schwab542,2300 00For
FRANKLIN STRATEGIC SERIES485,6000 00For
State Street399,1170 00For
Hartford397,7430 00For
Allspring393,7200 00For
BOSTON TRUST WALDEN FUNDS290,4810 00For
Brighthouse284,8900 00For
HARBOR FUNDS275,0600 00For
John Hancock234,5500 00For
Equitable205,3490 00For
Bridge Builder Trust197,6120 00For
HEARTLAND GROUP INC180,0000 00For
Columbia Threadneedle160,7310 00For
SCHWARTZ INVESTMENT TRUST151,0000 00For

Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).

The compensation of the Company's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

97% Approved · of votes cast

FOR 97%
FOR: 46,230,466AGAINST: 1,460,004

Prior year: 96.2% for (August 4, 2023 meeting) ▲ 0.7 pts

Details: description as filed, official tally, votes by 343 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers.

HAEMONETICS CORP.’s own tally for this item (“2. The compensation of the Company's named executive officers based upon the following votes”): 46,230,466 for, 1,460,004 against — passed, per its Form 8-K filed July 25, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 113 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at HAEMONETICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,196,3510 00For
Capital Group3,681,8750 00For
BlackRock3,247,0690 00For
AMCAP FUND3,053,4800 00For
Neuberger Berman2,265,1050 00For
Fidelity1,277,9810 00For
T. Rowe Price1,206,1850 00For
Royce1,017,8450 00For
Thrivent808,3220 00For
Dimensional763,3450 00For
Franklin Custodian Funds737,2640 00For
Charles Schwab542,2300 00For
FRANKLIN STRATEGIC SERIES485,6000 00For
State Street399,1170 00For
Hartford397,7430 00For
Allspring393,7200 00For
BOSTON TRUST WALDEN FUNDS290,4810 00For
Brighthouse284,8900 00For
HARBOR FUNDS275,0600 00For
John Hancock234,5500 00For
Equitable205,3490 00For
Bridge Builder Trust197,6120 00For
HEARTLAND GROUP INC180,0000 00For
Columbia Threadneedle160,7310 00For
SCHWARTZ INVESTMENT TRUST151,0000 00For

Fund voting reports, all 113 managers: 31,230,151 for, 148,002 against, 16,920 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 264 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at HAEMONETICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Capital Research Global Investors6,784,2160 00For
Neuberger Berman3,712,0420 00For
Wellington3,086,5720 00For
T. Rowe Price2,105,2080 00For
State Street1,680,59352 00For
BlackRock1,578,8876,441 00For
FRANKLIN ADVISERS INC1,271,1750 00For
GEODE CAPITAL MANAGEMENT, LLC1,137,4400 00For
Thrivent813,5500 00For
SCHRODER INVESTMENT MANAGEMENT GROUP733,0170 00For
Northern Trust574,7000 00For
MELLON INVESTMENTS Corp551,2740 00For
Charles Schwab545,4500 00For
WESTFIELD CAPITAL MANAGEMENT CO LP505,6499,258 00For
Allspring487,1480 00For
SILVERCREST ASSET MANAGEMENT GROUP LLC456,97513,087 00For
Boston Trust Walden Co306,9660 00For
LONDON CO OF VIRGINIA284,8820 00For
Aristotle Capital Boston, LLC271,5710 00For
Fisher Asset Management, LLC236,80621,684 00Mixed
Victory Capital235,8430 00For
Hood River Capital Management LLC229,1590 00For
PRINCIPAL GLOBAL INVESTORS208,0210 00For
Fidelity195,9490 00For
HEARTLAND ADVISORS INC188,3310 00For

Institutional-manager reports, all 264 managers: 31,750,527 for, 825,588 against, 104,478 abstained, 1,693 not voted. Showing the 25 largest; every one is in the interactive database (link above).

The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 47,738,769AGAINST: 1,049,682

Prior year: 98.5% for (August 4, 2023 meeting) ▼ 0.6 pts

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 29, 2025.

HAEMONETICS CORP.’s own tally for this item (“3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes”): 47,738,769 for, 1,049,682 against — passed, per its Form 8-K filed July 25, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 31,348,268 for, 28,543 against, 16,920 abstained.

FOR
FOR: 31,348,268AGAINST: 28,543ABSTAIN: 16,920
Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fi” at HAEMONETICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,196,3510 00For
Capital Group3,681,8750 00For
BlackRock3,247,0690 00For
AMCAP FUND3,053,4800 00For
Neuberger Berman2,265,1050 00For
Fidelity1,277,9810 00For
T. Rowe Price1,206,1850 00For
Royce1,017,8450 00For
Thrivent808,3220 00For
Dimensional763,3450 00For
Franklin Custodian Funds737,2640 00For
Charles Schwab542,2300 00For
FRANKLIN STRATEGIC SERIES485,6000 00For
State Street399,1170 00For
Hartford397,7430 00For
Allspring393,7200 00For
BOSTON TRUST WALDEN FUNDS290,4810 00For
Brighthouse284,8900 00For
HARBOR FUNDS275,0600 00For
John Hancock234,5500 00For
Equitable205,3490 00For
Bridge Builder Trust197,6120 00For
HEARTLAND GROUP INC180,0000 00For
Columbia Threadneedle160,7310 00For
SCHWARTZ INVESTMENT TRUST151,0000 00For

Showing the 25 largest of 114 asset managers. All 114 are in the interactive database (link above).

Not shown here: this season’s fund filings also report 11 items from the meeting of July 24, 2025, which belongs to the 2025-2026 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest HAEMONETICS CORP. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 51,152,886 shares outstanding at the time of that meeting.

Fund voting reports: top HAEMONETICS CORP. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 12.11%
2Capital Group 7.20%
3BlackRock 6.35%
4AMCAP FUND 5.97%
5Neuberger Berman 4.43%
6Fidelity 2.50%
7T. Rowe Price 2.36%
8Royce 1.99%
9Thrivent 1.58%
10Dimensional 1.49%
Institutional-manager reports: top HAEMONETICS CORP. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1Capital Research Global Investors 13.26%
2Neuberger Berman 7.26%
3Wellington 6.03%
4T. Rowe Price 4.12%
5State Street 3.29%
6BlackRock 3.10%
7FRANKLIN ADVISERS INC 2.49%
8GEODE CAPITAL MANAGEMENT, LLC 2.22%
9Thrivent 1.59%
10SCHRODER INVESTMENT MANAGEMENT GROUP 1.43%

Reported HAEMONETICS CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

HAEMONETICS CORP. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock6,357,164 12.43%Form 13F, quarter ended March 31, 2025
Vanguard Group5,099,621 9.97%Form 13F, quarter ended March 31, 2025
Neuberger Berman Group LLC3,531,181 6.90%Proxy statement (DEF 14A), proxy filed June 6, 2025
AQR Capital Management, LLC3,163,104 6.18%Schedule 13G, filed February 13, 2026
Vanguard Portfolio Management2,600,145 5.08%Schedule 13G, filed April 29, 2026
Wellington Management Group LLP2,203,351 4.31%Schedule 13G, filed August 12, 2025
T. Rowe Price Investment Management, Inc.2,195,569 4.29%Schedule 13G, filed May 14, 2025
State Street1,918,016 3.75%Form 13F, quarter ended March 31, 2025
Geode Capital1,221,367 2.39%Form 13F, quarter ended March 31, 2025
Dimensional Fund Advisors1,063,702 2.08%Form 13F, quarter ended March 31, 2025

Percentages above are of 51,152,886 shares outstanding, as reported by HAEMONETICS CORP. on its Form 10-Q dated June 29, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At HAEMONETICS CORP.'s shareholder meeting held July 25, 2024, in the 2024-2025 proxy season, 352 asset managers reported votes on at least one of its 11 ballot items in their SEC Form N-PX filings, covering 4,885 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — HAEMONETICS CORP.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: HAEMONETICS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on July 25, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from HAEMONETICS CORP.’s 10-Q dated June 29, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

HAEMONETICS CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “HAEMONETICS (HAE) 2024 Annual Meeting (2024-2025 season): Vote Results”, https://proxyvotesnow.com/company/haemonetics-corp/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.